Intellisense & Cognisense Technology Limited

Currently, the number of diabetes patients worldwide has exceeded 540 million, whilst the blood glucose monitoring market has reached US$44.5 billion. Traditional fingertip blood sampling still faces issues such as pain and infection risks. This project is based on organic thin-film transistor technology and has innovatively developed salivary glucose detection system. This system achieves an accuracy rate above 90% with continuous monitoring of key biomarkers such as glucose, uric acid, and lactate levels in real time, while effectively recording the dynamic changes of these metabolites during daily routines like eating and drinking, exercising, and everyday physical activities. This technology has been widely recognised by multiple international accolades, including the Gold Medal at the Geneva International Invention Exhibition, earning praises for its distinct advantages of high sensitivity, good selectivity, and low cost. It is set to provide a revolutionary non-invasive testing experience for diabetes patients worldwide, presenting a vast market for growth with promising prospects.

Key Team Member(s) 
Dr Zeyu ZHAO (Department of Applied Physics)